DE VERNEUIL VANINA (EVP, General Counsel, Corp Sec) sold 3.0% of their position (2.38K shares) of VIR BIOTECHNOLOGY, INC. on the open market
Open‑market sale worth $12.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/7/2025ACC: 0001628280-25-050592
Officer· EVP, General Counsel, Corp Sec
Since Feb 2026
-2.38K
Net shares
Net seller
$12.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
2.38K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2.38K
Price / share
$5.16
Trade value
$12.31K
% of position
3.0%
11/5/2025
80.59K→78.21K
Total
Net shares
−2.38K
Net value
-$12.31K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/5/2025 | S · Sale | −2.38K | $5.16 | $12.31K | 3.0% | 80.59K | 78.21K |
| Total | −2.38K | -$12.31K | ||||||
Derivative Transactions0
No derivative transactions reported